Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient

PURPOSE: Conventional wisdom has rendered patients with brain metastases ineligible for clinical trials for fear that poor survival could mask the benefit of otherwise promising treatments. Our group previously published the diagnosis-specific Graded Prognostic Assessment (GPA). Updates with larger...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Oncol
Hlavní autoři: Sperduto, Paul W., Mesko, Shane, Li, Jing, Cagney, Daniel, Aizer, Ayal, Lin, Nancy U., Nesbit, Eric, Kruser, Tim J., Chan, Jason, Braunstein, Steve, Lee, Jessica, Kirkpatrick, John P., Breen, Will, Brown, Paul D., Shi, Diana, Shih, Helen A., Soliman, Hany, Sahgal, Arjun, Shanley, Ryan, Sperduto, William A., Lou, Emil, Everett, Ashlyn, Boggs, Drexell H., Masucci, Laura, Roberge, David, Remick, Jill, Plichta, Kristin, Buatti, John M., Jain, Supriya, Gaspar, Laurie E., Wu, Cheng-Chia, Wang, Tony J.C., Bryant, John, Chuong, Michael, An, Yi, Chiang, Veronica, Nakano, Toshimichi, Aoyama, Hidefumi, Mehta, Minesh P.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2020
Témata:
Original Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7655019/
https://ncbi.nlm.nih.gov/pubmed/32931399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.01255
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky